Literature DB >> 11751846

Insulin acutely regulates Munc18-c subcellular trafficking: altered response in insulin-resistant 3T3-L1 adipocytes.

Bryce A Nelson1, Katherine A Robinson, Maria G Buse.   

Abstract

Preincubation of 3T3-L1 adipocytes in high glucose or glucosamine decreases acute insulin (100 nm)-stimulated glucose transport provided that insulin (0.6 nm) is included during preincubation. GLUT4 expression is unchanged (Nelson, B. A., Robinson, K. A., and Buse, M. G. (2000) Diabetes 49, 981-991). Munc18-c, a Syntaxin 4-binding protein, is a proposed regulator of the docking/fusion of GLUT4-containing vesicles with the plasma membrane. We examined the subcellular distribution of Munc18-c in response to acute (15-min) insulin (100 nm) stimulation after preincubation in 5 or 25 mm glucose +/- 0.6 nm insulin. Immunoblotting detected Munc18-c mainly in the Triton X-100-soluble plasma membrane (TS-PM) and the Triton X-100-insoluble low density microsomal (TI-LDM) fraction. Under each condition except high glucose + insulin preincubation, acute insulin increased Munc18-c (50-200%) in TS-PM and decreased Munc18-c (60%) in TI-LDM. Munc18-c traffic was time-dependent with a lag time of 3 min compared with GLUT4. Preincubation with high glucose + 0.6 nm insulin significantly impaired acute insulin-stimulated Munc18-c trafficking and decreased basal Munc18-c in the TI-LDM. Preincubation with glucosamine + insulin had similar effects. Total cellular Munc18-c remained unchanged. In conclusion, acute insulin stimulation promotes the translocation of Munc18-c, apparently from a TI-LDM-associated compartment to the TS-PM. Chronically increased glucose flux or exposure to glucosamine disrupts this process, which may negatively impact the fusion of GLUT4-containing vesicles with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751846     DOI: 10.1074/jbc.C100645200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis.

Authors:  Naira Baregamian; Jun Song; Marc G Jeschke; B Mark Evers; Dai H Chung
Journal:  J Surg Res       Date:  2006-09-26       Impact factor: 2.192

Review 2.  Hexosamines, insulin resistance, and the complications of diabetes: current status.

Authors:  Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01       Impact factor: 4.310

3.  Munc18c provides stimulus-selective regulation of GLUT4 but not fatty acid transporter trafficking in skeletal muscle.

Authors:  Swati S Jain; Laelie A Snook; Jan F C Glatz; Joost J F P Luiken; Graham P Holloway; Debbie C Thurmond; Arend Bonen
Journal:  FEBS Lett       Date:  2012-06-08       Impact factor: 4.124

4.  Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes.

Authors:  Katherine A Robinson; Lauren E Ball; Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-11-22       Impact factor: 4.310

Review 5.  Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4.

Authors:  Jenna L Jewell; Eunjin Oh; Debbie C Thurmond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-06       Impact factor: 3.619

6.  Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes.

Authors:  Zihao Wang; Kyoungsook Park; Frank Comer; Linda C Hsieh-Wilson; Christopher D Saudek; Gerald W Hart
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

7.  Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation.

Authors:  Katherine A Robinson; Maria G Buse
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-26       Impact factor: 4.310

Review 8.  Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.

Authors:  Chin Fen Teo; Edith E Wollaston-Hayden; Lance Wells
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

9.  Go-6976 reverses hyperglycemia-induced insulin resistance independently of cPKC inhibition in adipocytes.

Authors:  Katherine A Robinson; Krisztina Hegyi; Yusuf A Hannun; Maria G Buse; Jaswinder K Sethi
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.